North Capital’s PetMed Express PETS Stock Holding History

North Capital’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25	Closed	-$63	–	520
2025 Q3	$63	Hold	25	–	–	﹤0.01%	695
2025 Q2	$83	Hold	25	–	–	﹤0.01%	603
2025 Q1	$105	Buy	+25	New	+$114	﹤0.01%	609

Other funds holding PETS

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SPH

Steel Partners Holdings New York $96.4M AUM

North Capital's PETS Position: Q4 2025 in Review

North Capital sold out of PetMed Express (PETS) in Q4 2025, closing a stake of 25 shares — an estimated $63 sold.

North Capital first reported a position in PETS in Q1 2025 and held it in 3 quarters. The position peaked at $105 in Q1 2025. 51 funds tracked by Wall St. Rank hold PETS as of Q4 2025.

North Capital reported no remaining PetMed Express position as of Q4 2025 after selling out during the quarter.
North Capital sold 25 PetMed Express shares in Q4 2025, an estimated $63.
North Capital first reported a position in PetMed Express in Q1 2025 and held it in 3 quarters.
North Capital's PetMed Express position peaked at $105 in Q1 2025.
51 funds tracked by Wall St. Rank held PetMed Express as of Q4 2025.

Based on North Capital's 13F filing for Q4 2025, filed 18 Feb 2026.